Opportunities for improving opioid disposal practices in the Veterans Health Administration

被引:1
|
作者
Giannitrapani, Karleen F. [1 ,2 ]
Brown-Johnson, Cati [2 ]
McCaa, Matthew [1 ]
Mckelvey, Jeremiah [3 ]
Glassman, Peter [4 ,5 ]
Holliday, Jesse [1 ]
Sandbrink, Friedhelm [6 ]
Lorenz, Karl A. [1 ,2 ]
机构
[1] VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, Menlo Pk, CA 94025 USA
[2] Stanford Univ, Div Primary Care & Populat Hlth, Sch Med, Stanford, CA 94305 USA
[3] VA Northern Calif Hlth Care Syst, Mather, CA USA
[4] Dept Vet Affairs, Pharm Benefits Management Serv, Washington, DC USA
[5] UCLA, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[6] Washington VA Med Ctr, Washington, DC USA
关键词
disposal; diversion; opioids; public health; Veterans Affairs; UNITED-STATES; EPIDEMIC; CRISIS;
D O I
10.1093/ajhp/zxab163
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The potentially vast supply of unused opioids in Americans' homes has long been a public health concern. We conducted a needs assessment of how Veterans Affairs (VA) facilities address and manage disposal of unused opioid medications to identify opportunities for improvement. Methods. We used rapid qualitative content analysis methods with team consensus to synthesize findings. Data were collected in 2 waves: (1) semistructured interviews with 19 providers in October 2019 and (2) structured questions to 21 providers in March to April of 2020 addressing how coronavirus disease 2019 (COVID-19) changed disposal priorities. Results. While many diverse strategies have been tried in the VA, we found limited standardization of advice on opioid disposal and practices nationally. Providers offered the following recommendations: target specific patient scenarios for enhanced disposal efforts, emphasize mail-back envelopes, keep recommendations to providers and patients consistent and reinforce existing guidance, explore virtual modalities to monitor disposal activity, prioritize access to viable disposal strategies, and transition from pull to push communication. These themes were identified in the fall of 2019 and remained salient in the context of the COVID-19 pandemic. Conclusion. A centralized VA national approach could include proactive communication with patients and providers, interventions tailored to specific settings and populations, and facilitated access to disposal options. All of the above strategies are feasible in the context of an extended period of social distancing.
引用
收藏
页码:1216 / 1222
页数:7
相关论文
共 50 条
  • [41] Perioperative opioid use and pain-related outcomes in the Veterans Health Administration
    Hernandez-Boussard, Tina
    Graham, Laura A.
    Carroll, Ian
    Dasinger, Elise A.
    Titan, Ashley L.
    Morris, Melanie S.
    Hawn, Mary T.
    AMERICAN JOURNAL OF SURGERY, 2020, 219 (06): : 969 - 975
  • [42] Best Practices of Recruiting Family Caregivers in Health Services Research in the Veterans Health Administration
    Trivedi, Ranak
    PSYCHO-ONCOLOGY, 2025, 34
  • [43] Providers' and Administrators' Perceptions of Complementary and Integrative Health Practices Across the Veterans Health Administration
    Fletcher, Carol E.
    Mitchinson, Allison R.
    Trumble, Erika
    Hinshaw, Daniel B.
    Dusek, Jeffery A.
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2017, 23 (01) : 26 - 34
  • [44] Core implementation strategies for improving cirrhosis care in the Veterans Health Administration
    Yakovchenko, Vera
    Morgan, Timothy R.
    Miech, Edward J.
    Neely, Brittney
    Lamorte, Carolyn
    Gibson, Sandra
    Beste, Lauren A.
    McCurdy, Heather
    Scott, Dawn
    Gonzalez, Rachel, I
    Park, Angela M.
    Powell, Byron J.
    Bajaj, Jasmohan S.
    Dominitz, Jason A.
    Chartier, Maggie
    Ross, David B.
    Chinman, Matthew J.
    Rogal, Shari S.
    HEPATOLOGY, 2022, 76 (02) : 404 - 417
  • [45] Veterans Health Administration
    Skarl, Susie
    JOURNAL OF CONSUMER HEALTH ON THE INTERNET, 2016, 20 (04) : 173 - 179
  • [46] Challenges and opportunities related to penicillin allergy in the Veterans Health Administration: a narrative review
    Kouma, Marcus A.
    Guastadisegni, Jessica M.
    Yang, Linda
    Maxwell, Daniel N.
    Storey, Donald F.
    Arasaratnam, Reuben J.
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2023, 3 (01):
  • [47] Delivering a "New Deal" of Kidney Health Opportunities to Improve Outcomes Within the Veterans Health Administration
    Crowley, Susan T.
    Murphy, Katherine
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 72 (03) : 444 - 450
  • [48] Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration
    Ching, Jack H.
    Owens, Douglas K.
    Trafton, Jodie A.
    Goldhaber-Fiebert, Jeremy D.
    Salomon, Joshua A.
    ADDICTION, 2021, 116 (12) : 3494 - 3503
  • [49] Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration
    Manhapra, Ajay
    Quinones, Lantie
    Rosenheck, Robert
    DRUG AND ALCOHOL DEPENDENCE, 2016, 160 : 82 - 89
  • [50] Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what?
    Manhapra, Ajay
    Stefanovics, Elina
    Rosenheck, Robert
    SUBSTANCE ABUSE, 2020, 41 (01) : 110 - 120